Press about RVC

RVC's Daughter Company Successfully Tests Industrial Exoskeleton
29.05.2020
The ExoAtlant company, a spin-off of the portfolio company of the RVC ExoAtlet Biofund portfolio, tested an industrial exoskeleton jointly with the “Scientific Research Institute of Occupational Medicine named after Academician NF. Izmerov.” The study results showed the safety and effectiveness of the development in those areas of production where physical labor associated with lifting and holding weights is used.
In 2019, the Russian venture capital market grew in volume: According to DSight and E&Y, start-up investments exceeded $868 million. However, in 2020, the industry is likely to decline due to the pandemic, which put many business processes on a forced pause, and investment activity also decreased significantly. How can a start-up survive in such conditions?
Russian Venture Company, which supervises the development of the Competence Centers of the National Technological Initiative in the status of an operator, sums up the results of the first one and a half years of work of structures that were created to accelerate Russia's entry into the technology markets of the future.
The innovative industry also suffered from the crisis associated with COVID – 19: many start-ups were at risk. But there are those who managed to reformat their business in time for current needs. Ekaterina Petrova, Director of GenerationS Corporate Accelerator, spoke about successful examples from its practice.


Search by name:

Search by date:

Select date in calendar
Select date in calendar
Venue: